GRACE is excited to bring to our Spanish speaking community - Cancer Basics Dr. Duma is an Assistant Professor and Thoracic Oncologist at @UWcarbone...
GRACE is excited to bring you new information in our Bladder Cancer Program, hosted by Ramy Sedhom, MD. For this video, Dr. Ramy Sedhom introduces us...
GRACE is very excited to bring you more info from our new program, Supportive Care in Cancer Treatment. Ramy Sedhom, MD, with Johns Hopkins in...
GRACE is excited to bring to our Spanish speaking community - Cancer Basics Dr. Duma is an Assistant Professor and Thoracic Oncologist at @UWcarbone...
GRACE is excited to bring you new information in our Bladder Cancer Program, hosted by Ramy Sedhom, MD. For this first video of 2019, Dr. Ramy Sedhom...
From the Grace Archives | Originally Published July 30, 2010 | By Dr West | 13 Comments GRACE member and forum moderator Catharine started a forum...
For our Mandarin speaking community, Jenny J. Li, MD, Hematology/Oncology Fellow at the Mayo Clinic in Rochester MN, offers translated updates to our Lung Cancer Video Library.
In this video translation, Dr. Li discusses Immunotherapy Combinations in Advanced Squamous Non-Small Cell Lung Cancer.
For our Mandarin speaking community, Jenny J. Li, MD, Hematology/Oncology Fellow at the Mayo Clinic in Rochester MN, offers translated updates to our Lung Cancer Video Library.
In this video translation, Dr. Li discusses whether immunotherapy works in patients with driver mutations like EGFR and ALK.
I've been on Tagrisso since July 2017. I had great initial response with all visible cancer shrinking to the point of no longer being detected except for one solitary nodule that shrank from 1.8 cm to .6 cm. In August 2018, a scan showed the nodule had doubled in size in 10 weeks and a met appeared on a rib. The nodule was radiatied. Scans Dec 2018 showed the nodule had again reduced to about .5 cm, the rib met remained stable and another rib met appeared to be developing.
For our Mandarin speaking community, Jenny J. Li, MD, Hematology/Oncology Fellow at the Mayo Clinic in Rochester MN, offers translated updates to our Lung Cancer Video Library.
In this video translation, Dr. Li discusses immunotherapy combinations in advanced non-squamous non small cell lung cancer.
This article was provided by Disability Benefits Help, an independent organization dedicated to helping people of all ages get Social Security disability benefits.
My husband has the following values for kidney function:
Creatinine: 1.36 (normal range .8 - 1.25)
Urea: 68 (normal range 15 - 53)
Would these values be generally acceptable to get a PET/CT scan ? to be ok getting the
dye/glucose injections? If so, should he get iv fluids before and/or after the injection to
assist in flushing the kidneys?
We are in Greece and I don't see a EGFR or BUN listed on his bloodwork, just these #'s
At ASCO 2018, Dr. Melissa Loh presented a study titled: "Chance of Cure in Advanced Cancer: What Do Older Patients Believe and How Are These Beliefs Related to Their Preferences?". This study looked at patients and their beliefs regarding a cure for cancer, specifically in older patients with advanced cancer. Patients who are certain that they could be cured pose unique challenges for physicians and shows a need for clear communication between patients and their physicians regarding the outcome of treatment and quality of life.
Drs. H. Jack West, Medical Director - Thoracic Oncology Program at Swedish Cancer Institute, President and CEO of GRACE, Karen Kelly - Associate Director for Clinical Research at UC Davis Comprehensive Cancer Center, and Sandip Patel - Medical Oncologist and Associate Professor of Medicine at Moores Cancer Center, UC San Diego Health, gathered post meeting to discuss new information from ASCO 2018 regarding lung cancer.
In this roundtable video, the doctors discuss the Dream Study - combining chemotherapy with Imfinzi (Durvalumab) for mesothelioma.
Drs. H. Jack West, Medical Director - Thoracic Oncology Program at Swedish Cancer Institute, President and CEO of GRACE, Karen Kelly - Associate Director for Clinical Research at UC Davis Comprehensive Cancer Center, and Sandip Patel - Medical Oncologist and Associate Professor of Medicine at Moores Cancer Center, UC San Diego Health, gathered post meeting to discuss new information from ASCO 2018 regarding lung cancer.
In this roundtable video, the doctors discuss Keynote 158 - treating with Keytruda in previously treated, now relapsing patients with SCLC.
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.